| Product Code: ETC8619524 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Bacteriophages Therapy Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Nigeria Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Nigeria Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Nigeria Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Nigeria Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Nigeria Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Nigeria Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections in Nigeria |
4.2.2 Growing awareness about the benefits of bacteriophage therapy as an alternative to antibiotics |
4.2.3 Supportive government initiatives to promote research and development in bacteriophage therapy |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of bacteriophage therapy among healthcare professionals and patients |
4.3.2 Lack of standardized regulations and guidelines for the use of bacteriophages in therapy |
4.3.3 Challenges in scaling up production and distribution of bacteriophage products |
5 Nigeria Bacteriophages Therapy Market Trends |
6 Nigeria Bacteriophages Therapy Market, By Types |
6.1 Nigeria Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Nigeria Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Nigeria Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Nigeria Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Nigeria Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Nigeria Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Nigeria Bacteriophages Therapy Market Export to Major Countries |
7.2 Nigeria Bacteriophages Therapy Market Imports from Major Countries |
8 Nigeria Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted in Nigeria for bacteriophage therapy |
8.2 Adoption rate of bacteriophage therapy in hospitals and healthcare facilities |
8.3 Investment in research and development for new bacteriophage products |
8.4 Number of partnerships and collaborations between local and international pharmaceutical companies in the bacteriophage therapy market |
8.5 Patient outcomes and success rates of bacteriophage therapy treatments |
9 Nigeria Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Nigeria Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Nigeria Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Nigeria Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Nigeria Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Nigeria Bacteriophages Therapy Market - Competitive Landscape |
10.1 Nigeria Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here